SHORT (STI) AND LONG TERM INFUSION (LTI) OF CH14.18/CHO IMMUNOTHERAPY: TOXICITY PROFILES AND OUTCOMES IN 530 HIGH RISK NEUROBLASTOMA (HR-NBL) PATIENTS IN TWO SIOPEN TRIALS

PEDIATRIC BLOOD & CANCER(2015)

引用 0|浏览3
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要